Company:OrCam device

OrCam

Type	Private company
Industry	Health, Assistive technology
Founded	2010 (2010) Jerusalem
Founder	Ziv Aviram Amnon Shashua
Headquarters	Har Hotzvim, Jerusalem, Israel
Key people	Prof Amnon Shashua (Chairman and CTO) Ziv Aviram (President and CEO) Dr. Yonatan Wexler (Executive VP of R&D)
Products	OrCam MyEye and OrCam MyReader
Number of employees	150 (2018)
Website	http://www.orcam.com/

OrCam Technologies Ltd. is an Israeli-based company producing wearable artificial intelligence space. OrCam develops and manufactures assistive technology devices for individuals who are visually impaired, partially sighted, blind, print disabilities, or have other disabilities. OrCam headquarters is located in Jerusalem operating under the company name OrCam Technologies Ltd.

History

OrCam Technologies Ltd was founded in 2010 by Professor Amnon Shashua and Ziv Aviram. Before co-founding OrCam, the two in 1999 co-founded Mobileye, an Israeli company that develops vision-based advanced driver-assistance systems (ADAS) providing warnings for collision prevention and mitigation, which was acquired by Intel for $15.3 billion in 2017. OrCam launched OrCam MyEye in 2013 after years of development and testing, and began selling it commercially in 2015. In its early years, the company raised $22 million, $6 million of which from Intel Capital. In March 2017, OrCam had raised $41 million in capital, making it worth $600 million. Today, OrCam has over 150 employees, is headquartered in Jerusalem, and has offices in New York, Toronto, and London.

Devices

OrCam Technologies Ltd has created three devices; OrCam MyEye 2.0, OrCam MyEye 1, and OrCam MyReader.

OrCam My Eye 2.0:

OrCam MyEye 2.0

• OrCam debuted the second-generation model, the OrCam MyEye 2.0 in December 2017.
• About the size of a finger, the MyEye 2.0 is battery-powered, and has been compressed into a self-contained device.
• The device snaps onto any eyeglass frame magnetically.
• Orcam 2.0 is smaller and lighter (only 22.5 grams/0.8 ounces) with more functionality to restore independence to the visually impaired.

Clinical Studies

JAMA Opthomology: In 2016 JAMA Opthomology conducted a study involving 12 legally blind participants to evaluate the usefulness of a portable artificial vision device (OrCam) for patients with low vision. The results showed that the OrCam device improved the patient’s ability to perform tasks simulating those of daily living, such as reading a message on an electronic device, a newspaper article or a menu.

Wills Eye: Wills Eye was a clinical study designed to measure the impact of the OrCam device on the quality of life of patients with End-stage Glaucoma. The conclusion was that OrCam, a novel artificial vision device using a mini-camera mounted on eyeglasses, allowed legally blind patients with end-stage glaucoma to read independently, subsequently improving their quality of life.

Awards

• 2018 Last Gadget Standing Winner
• 2018 CES Innovation Awards Honoree in Accessible Tech
• 2017 NAIDEX Innovation Award
• 2016 Louise Braille Corporate Recognition Award
• 2016 Silmo-d-Or Award

External links

• OrCam Facebook page
• Foundation Fighting Blindness website
• National Center for Health Statistics website